Skip to content

Clinical trials

Multiple Endocrine Neoplasia Type 1 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Country / region: United States Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20062
20072
20081
20094
20105
20113
20122
20133
20144
20154
20161
20176
20188
20194
20204
20213
20223
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Recruiting8
Terminated4
Unknown status4
Active, not recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arizona State University4
M.D. Anderson Cancer Center3
National Cancer Institute (NCI)3
Novartis Pharmaceuticals3
Bayer2
Florida State University2
Medical College of Wisconsin2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Ohio State University Comprehensive Cancer Center2
Premier Research2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 171
Breast Neoplasms6
Prostatic Neoplasms6
Obesity5
Pancreatic Neoplasms4
Weight Loss4
Hot Flashes3
Infertility3
Neuroendocrine Tumors3
von Hippel-Lindau Disease3

Trials

Showing 51 to 71 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.